CS Paper Radar

TCMScience: An Autonomous Scientist for Traditional Chinese Medicine

Yanlan Kang, Ruiqi Liu, Xinpei Gu, Tzu-Yi Lei, Shuai Xu, Xukun Zhang, William Cheng-Chung Chu

cs.LG ·submitted 2026-10-17 10:06 UTC · v1
code/data

Abstract

Traditional Chinese medicine (TCM) research connects classical texts, medicinal entities, molecular assays, computational predictions, and clinical studies. An autonomous research agent must preserve the inferential boundaries between these evidence types while coordinating analysis across heterogeneous resources. We introduce TCMScience, a scientific knowledge-discovery agent that separates language-model proposals from execution and release authority. Its architecture combines a trusted kernel, a scientific compiler, and claim-support contracts: plans are compiled into typed operations, execution is bounded by explicit permissions, and candidate findings are checked against source provenance, study design, and claim scope before release. The full capability registry contains 117 public-source connectors with 444 typed operations across 29 domains and 150 native tools across 12 domains; the TCM data hub catalogs 136 databases, 76 dataset specifications, and 84,294 formula-source records. These resources support model-independent workflows through browser and local execution interfaces. In a network-pharmacology analysis of Gegen Qinlian Tang, replacing the whole-proteome background with the assayed-protein background changed the number of significant pathways from 66 to zero; incorporating inactive screening records identified nine pathways, including drug-metabolism signals retained as mechanistic hypotheses. A governance ablation over 121 constructed erroneous outputs spanning 26 classes released 121 errors without governance, 57 with the domain layer, seven with the kernel, and zero with both layers. All 10 compliant controls were retained. These results establish complementary control of known failure modes and show how explicit evidence contracts change the conclusions an agent is permitted to report.

Comment
21 pages, 3 figures, including appendices. Code: https://github.com/IMPF-AI-Institute/TCMScience

Closest papers

Nearest neighbours by meaning across the whole index.

DrugCoding: A Scientific Programming Agent for Drug Discovery

cs.AI cs.MA ·2026-11-10 ·Junwei Hu, Zhuohao Lin, Kun Li, Hengnan Zhang
benchmark similarity 0.67
Abstract

Drug discovery involves multiple interconnected research stages, including molecular design, property prediction, and virtual screening. These processes are characterized by complex workflows, interdependent computational tasks, and diverse specialized tools, placing substantial demands on the coordination of scientific models and computational resources. However, existing large language model (LLM)-based scientific agents still face challenges in autonomous planning of complex tasks, adaptive selection of specialized models, and reliable execution of multi-stage scientific computations, limiting their effectiveness in automating complex drug discovery workflows. To address these challenges, we propose DrugCoding, a scientific programming agent system that integrates scientific task planning, adaptive model routing, multi-agent collaboration, and programmatic tool execution. DrugCoding enables autonomous task planning and dynamic model adaptation for complex research objectives. It can flexibly invoke specialized scientific models, autonomously generate and execute code according to task requirements, and leverage multi-agent collaboration to support efficient execution and reliable validation of complex scientific tasks. To evaluate DrugCoding's performance in scientific tool invocation and multi-stage task execution, we conduct multi-turn tool-calling experiments across diverse language models and scientific tool interfaces. Experimental results demonstrate that DrugCoding achieves an average session-level Pass@1 of 97.35% on the full benchmark, outperforming the strongest baseline, Codex, by 9.24%. On the challenging subset, DrugCoding achieves 97.92%, exceeding the strongest baseline.

0.18

SciCurateBench: Curating Experimental Data from Heterogeneous Scientific Literature with Verbal-Action Agents

cs.CL ·2026-10-09 ·Minuk Ma, Kaiyun Guo, Jiarui Ding
benchmark similarity 0.66
Abstract · 19 pages, 4 figures, 13 tables

Scientific research increasingly depends on curating experimental data from literature. Scientific data curation requires verifying exact experimental conditions (e.g., specific assays, clinical outcomes, and data availability) across long, heterogeneous files, which is a highly time-consuming process. Existing benchmarks evaluate only broad relevance on short queries, failing to capture this complexity. We introduce SciCurateBench, a benchmark of 200 expert-annotated papers from major life-science journals that challenges systems to verify conjunctive biological experimental criteria from raw, unprocessed scientific literature. We show that plain LLMs and popular reasoning, tool-using, and feedback-based agents all struggle with this task. To study what makes the task tractable, we further propose LangPoli, an integrative system in which a policy agent generates natural language action guidelines that actor agents convert into executable tools. LangPoli showed strong performance on both Paper Classification (83.16% F1 vs. 58.22% for its base LLM) and Structured Information Retrieval, and also improves re-ranking on the public benchmarks of LitSearch, BEIR, and TREC. We further explore curriculum transfer, a method that distills generalizable strategies from solved tasks to accelerate the solving of related problems. We hope this work facilitates research in truly practical scientific AI assistance. The anonymized pre-release can be found from https://anonymous.4open. science/r/scicuratebench-D885/.

0.25

El Agente Fármaco: A Scalable AI Scientist for Drug Discovery

cs.AI cs.MAq-bio.BM ·2026-11-02 ·Marcel Müller, Mohammad Ghazi Vakili, Yoshihiro Ogura, Ella Ashoori, Shimeng Wang +11 more
benchmark similarity 0.65
Abstract · 63 pages, 13 figures, including Supporting Information

Computational drug discovery offers a growing range of tools for proposing and evaluating molecules, but combining them and deciding what to do next still requires substantial expert effort. Here, we introduce El Agente Fármaco, an AI scientist that uses modern large language model (LLM) technology to turn discovery goals expressed in everyday language into complex, scalable computational screening workflows. The agentic harness selects scientific tools, reviews their results, and adjusts subsequent steps to the target and the user's objectives. Our approach centers on a shared scientific memory: Fármaco Atlas, which stores molecules, structures, and results together with their provenance -- a record of how they were obtained. The agent uses targeted database queries to retrieve the evidence needed for each decision. A single request can launch calculations for an entire collection of molecules, without requiring a separate LLM decision for every compound. This design limits the information the model must process as screening collections grow, while keeping the underlying results available for inspection and further analysis. The integrated tools support molecule generation, prediction of binding and molecular properties, and searches for compounds available for purchase. In a retrospective comparison with an expert-led campaign, the agent proposed chemically distinct candidates with competitive docking scores and higher calculated drug-likeness under explicitly imposed selection criteria. In a 22-task benchmark against plain tool calls and Codex, the agent achieved the highest observed mean model-judged score, with lower median cumulative token use and peak context. Fármaco provides a foundation for flexible, scalable drug discovery workflows that connect scientific reasoning with an enduring, traceable record of computational work.

0.08

Can LLMs Reliably Annotate Bioassay Metadata to Improve Data Readiness?

cs.CL cs.AIcs.DBq-bio.QM ·2026-10-01 ·Laura van Weesep, Riccardo Tedoldi, Jens Sjölund, Hossein Azizpour, Susanne Winiwarter +4 more
publishedcode/data similarity 0.65
Abstract · Accepted to the AIDaR workshop at NeurIPS

The emergence of foundation models for molecular property prediction requires a high degree of AI data readiness, including reliable metadata annotation. However, both public repositories and industrial screening databases suffer from missing, inconsistent, or conflated assay annotations. In this work, we quantify the extent of missing annotations in PubChem for the BioAssay Ontology (BAO) assay format and physical detection method fields and investigate whether open-source and proprietary large language models (LLMs) can reliably predict and audit metadata annotations directly from the assay text. In our assessment, we found that the annotation coverage across PubChem's $\sim$2 million bioassays is critically sparse, 36\% lacking an assay format, 89\% a BioAssay type, and >99.9\% any BAO-mapped assay format or detection technology term. This motivates the need for automated test-metadata curation. Using evaluation sets derived from PubChem and ChEMBL, we assess the agreement of seven open-source and proprietary LLMs with existing silver labels. Recall is at least 0.96 for biochemical and cell-based assay formats, with a similar pattern for detection technology, although disagreements increase on under-represented classes. Manual inspection shows that many of these disagreements trace back to inconsistencies between silver sources rather than to LLM error. Moreover, in a qualitative study with a senior industrial curator, LLM-generated evidence prompted the expert to revise some of their own labels, showing LLMs can flag potentially mislabeled assays. Across the study, performance differences between proprietary and open-source models were small. Together, these results suggest LLMs can support the large-scale annotation and auditing of assay metadata, though per-class reliability estimates and targeted human review remain necessary before such labels enter downstream ML pipelines.

0.47

Bioinfoysis Technical Report

cs.AI cs.MA ·2026-09-03 ·Qingyang Shao, Xin Zhang, Zhouyang Yuan, Xianying Chen, Yujia Xiang +22 more
similarity 0.64
Abstract

Large language model agents have shown promise in bioinformatics, but most existing systems focus primarily on producing final answers, treating planning, tool use, and code execution as transient interactions. This design is poorly suited to long-horizon bioinformatics tasks, where conclusions must remain connected to the data, computations, and intermediate evidence that support them. We introduce \textbf{Bioinfoysis}, a multi-agent harness that represents each request as a persistent, artifact-grounded analysis run. Bioinfoysis combines global planning with step-wise, evidence-driven replanning: the planner maintains an executable checklist and revises pending steps using structured handoffs returned after each worker execution. These handoffs bind intermediate results to their responsible agent, checklist step, and plan generation, preventing stale evidence from being silently reused after replanning. A controlled runtime validates generated scripts, tables, and figures before they are used in downstream analysis or reporting, while role-specific context, persistent memory, and governed bioinformatics skills support reliable execution over long analysis trajectories. We evaluate Bioinfoysis on BixBench and two question-answering tracks of LAB-Bench 2. On BixBench, Bioinfoysis achieves state-of-the-art accuracy of 82.4\%. Across four underlying language models, Bioinfoysis increases average accuracy from 27.81\% to 64.13\% on SeqQA2 and from 3.13\% to 31.25\% on DbQA2. These results demonstrate that reliable bioinformatics automation depends not only on model capability, but also on the harness that governs planning, execution, memory, and evidence flow. We hope that the emergence of Bioinfoysis will play a driving and leading role in the development of the bioinformatics community. Our demo website can be seen in https://report.bioinfoysis.com/.

0.27

OpenAI4S: Code as Action, Science as Sessions

cs.AI cs.CLcs.SE ·2026-09-14 ·Gongbo Zhang, Hao Li, Yu Wang, Mujie Lin, Liuzhenghao Lv +13 more
code/data similarity 0.64
Abstract

AI co-scientists could accelerate computational research, but over a long-running study the workflow also has to stay inspectable, resumable and reproducible, which requires persistent computational state and provenance. Here we present OpenAI4S, an open-source scientific research agent built around the principle of \emph{Code as Action, Science as Sessions}. OpenAI4S combines a persistent computing runtime with research-session management: orchestration is handled through structured tool calls, while scientific actions are represented as complete code cells executed in persistent Python and R kernels. An append-only Action Ledger, per-cell execution records, versioned artifacts, environment records, and workspace checkpoints preserve how results were produced and support session recovery, branching, and extension. Configurable sandboxing, permission controls, and code and trajectory screening provide complementary safeguards. We evaluate OpenAI4S on 36 research scenarios spanning retrosynthesis, molecular dynamics, protein binder design, protein mutation, catalyst screening, and mineral spectroscopy, measuring scientific task accuracy, workflow completeness, and reproducibility of the resulting repositories. OpenAI4S achieves an overall score of 7.83, compared with 5.7--6.4 for a general-purpose coding harness evaluated with three frontier models, with the largest gains on long-horizon and computation-intensive workflows. These results suggest that integrating persistent execution with session-level provenance can improve the reliability of AI-assisted scientific workflows. Environment specification and full rerunnability remain weak for every evaluated system, ours included, so reproducibility is still an open problem for scientific agents. The system is available under the MIT license at \href{https://github.com/PKU-YuanGroup/OpenAI4S}{github.com/PKU-YuanGroup/OpenAI4S}.

0.23

AI-Driven Reproducibility and Analytical Robustness in Scientific Discovery

cs.AI cs.CL ·2026-10-16 ·Shicheng Liu, Krista Opsahl-Ong, Andrew Drozdov, Julian Killingback, Arnav Singhvi +4 more
benchmark similarity 0.64
Abstract

Reproducible and analytically robust research findings are essential to scientific progress, but evaluating these properties typically requires costly manual effort. We investigate whether LLM agents can help automate reproduction and robustness analysis, using a medical case study grounded in the Surveillance, Epidemiology, and End Results (SEER) database, a widely used U.S. cancer registry underlying tens of thousands of published studies. First, we introduce SEER-Repro, a benchmark of 20 published SEER-based papers together with the data and resources required to reproduce their findings. Second, we create an AI agent that successfully reproduces 77.4% of 2,190 atomic claims, while providing executable baselines for further analysis. Third, we develop an agentic analysis pipeline to test the robustness of the medical findings by identifying analytical choices underlying each finding, proposing defensible alternatives, and rerunning the analysis to determine whether those choices affect the conclusion. Across published papers in SEER-Repro, our pipeline identifies potentially consequential analytical choices in 9.5% of fully reproduced findings and flags them for expert review. These results show how LLM agents can support scientific review by reproducing findings, systematically testing their robustness, and directing expert attention toward potentially consequential analytical choices.

0.22

Auditing Tool Traces in Agentic LLMs: Source Localization and Counterfactual Dependence Testing

cs.AI cs.CL ·2026-10-18 ·Junhao Liu, Tianxiao Li, Yongxian Wu, Ziheng Duan, Ren Li +2 more
publishedbenchmarkhot direction similarity 0.63
Abstract · 12 pages. Accepted at the NeurIPS 2026 Workshop on Agentic AI for Biological Discovery (AgenticLS)

Agentic LLMs increasingly support scientific prediction by grounding decisions in external evidence. In biology, they promise accurate, interpretable predictions for important problems by integrating complex experimental and computational evidence. However, serialized tool results can contain hidden label shortcuts, such as dataset identifiers or template artifacts, that create apparent success without biological reasoning. To address this risk, we introduce a two-stage audit. Stage 1, Per-Tool TF-IDF Decomposition (PT2D), localizes label-predictive patterns to individual tool results while avoiding signal dilution in the concatenated tool trace. Stage 2, Token-Class Redaction, counterfactually tests whether the frozen LLM depends on the localized shortcut. We apply this audit to TCR-pMHC binding, where tool augmentation substantially outperforms a no-evidence baseline. At face value, this suggests that the LLM has learned to use scientific evidence. The audit overturns this interpretation: PT2D localizes the strongest signal to identifiers in one tool result, and redacting them reduces performance to chance. These findings show how hidden label shortcuts can masquerade as scientific reasoning or discovery, motivating source-level audits before benchmark gains are trusted.

0.38